Startups
Kimera Labs is a leading exosome biotechnology laboratory that specializes in the production of perinatal mesenchymal stem cell-derived (MSC) exosome products for cosmetic use and scientific and clinical research. They offer optimal-purity, isolated stem cell exosomes. Kimera Labs also provides MSC Exosome Therapeutics and Diagnostics.
However, according to Owler, Kimera Labs’s primary competitors include Evox, Kymab, Aegle Therapeutics and 12 more.
However, according to Owler, Kimera Labs’s primary competitors include Evox, Kymab, Aegle Therapeutics and 12 more.
Overview
Location
United States, Florida, Miramar
Employees
11-50
Founded date
2012
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 11, 2021 | Kimera Labs Announces New Standard Measurement For Exosome Potency, Characterization |
Reviews 0
FAQ about Kimera Labs Inc
When was Kimera Labs Inc founded?
Kimera Labs Inc was founded in 2012.
What has the press written about Kimera Labs Inc?
Parsers VC has collected 2 articles mentioning Kimera Labs Inc, among them “Kimera Labs Announces New Standard Measurement For Exosome Potency, Characterization” (Mar 11, 2021).
Is Kimera Labs Inc still active?
Yes, Kimera Labs Inc is active; its latest activity on Parsers VC dates from Mar 9, 2023.